Heartflow logo

Heartflow

HTFL | NASDAQ
Chart Builder DCF Calculator
$46.86
-$1.60 (-3.30%)
At close: Nov 16, 2026, 4:00 PM ET
$47.68
+$0.82 (+1.75%)
After-hours: Nov 16, 2026, 7:30 PM ET
-3.30%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
47.1
+1.4 pts
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #343/1021 (Top 34%)

Key Statistics

Market Data

Market Cap $4.12B
1D Range
46.41 49.36
52W Range
20.49 60.53

Valuation (TTM)

PE -50.93
PB 14.58
EV/EBITDA -55.11

Valuation (NTM)

Forward PE N/A
Forward PEG 0.64
Price Target $55.00
Loading financial charts...

Profile

HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative Heart...

Sector Healthcare
Employees 843
IPO Date Aug 7, 2025
Fiscal Year January - December

Latest News

HeartFlow: 3 Key Takeaways for Long-Term Investors

3 days ago · fool.com

HeartFlow: 3 Key Takeaways for Long-Term Investors
HeartFlow, Inc. (HTFL) Q3 2026 Earnings Call Transcript

4 days ago · seekingalpha.com

HeartFlow, Inc. (HTFL) Q3 2026 Earnings Call Transcript
What Heartflow (HTFL) Said on Its Q3 Earnings Call

4 days ago · marketbeat.com

What Heartflow (HTFL) Said on Its Q3 Earnings Call
HeartFlow (HTFL) Reports Q3 Loss, Beats Revenue Estimates

4 days ago · zacks.com

HeartFlow (HTFL) Reports Q3 Loss, Beats Revenue Estimates
AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE Registry

15 days ago · globenewswire.com

AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE Registry
Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026

28 days ago · globenewswire.com

Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026
HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High

2 months ago · fool.com

HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

3 months ago · globenewswire.com

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half
Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference

3 months ago · globenewswire.com

Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference
HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?

3 months ago · fool.com

HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$0.03
Beat +70.85%
REV
$72.86M
Beat +11.75%
Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
6
Consensus
Buy
Price Target
$55.50
Upside
+18.44%
Buy (5)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.